The Prevalence of Potential Drug-Drug Interactions in Patients with Heart Failure at Hospital Discharge

被引：0
|
作者：
Bernhard Straubhaar
Stephan Krähenbühl
Raymond G. Schlienger
机构：
[1] University of Basel,Department of Pharmaceutical Sciences, Institute of Clinical Pharmacy
[2] University Hospital of Basel,Division of Clinical Pharmacology and Toxicology
来源：
Drug Safety | 2006年 / 29卷
关键词：
Amiodarone; International Normalise Ratio; Heart Failure Patient; Carvedilol; Spironolactone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background/objective: Pharmacotherapy for heart failure is complex and, due to polypharmacy, is associated with a large risk of potential drug-drug interactions (DDIs). The objective of the present study was to assess the prevalence of potential DDIs in the medication of hospitalised heart failure patients and to evaluate their clinical relevance.
引用
收藏
页码：79 / 90
页数：11
相关论文
共 50 条
  • [21] Evaluation of Potential Drug-Drug Interactions in Hypercholesterolemia Patients at Teaching Hospital Surabaya
    Faizah, Ana Khusnul
    Nurrahman, Nani Wijayanti Dyah
    PROCEEDINGS OF THE 4TH INTERNATIONAL CONFERENCE ON SUSTAINABLE INNOVATION 2020 - HEALTH SCIENCE AND NURSING (ICOSIHSN 2020), 2021, 33 : 302 - 304
  • [22] DRUG-DRUG INTERACTIONS IN HOSPITAL
    MOK, H
    MULPETER, K
    OCONNOR, P
    FEELY, J
    IRISH MEDICAL JOURNAL, 1991, 84 (01) : 26 - 26
  • [23] Prevalence and factors associated with potential clinically significant drug-drug interactions in patients with cardiovascular diseases at hospital admission
    Marovic, Iva
    Udovicic, Mario
    Rudan, Diana
    Manola, Sime
    Samardzic, Ivana
    Vrca, Vesna Bacic
    Hadziabdic, Maja Ortner
    Marinovic, Ivana
    ACTA PHARMACEUTICA, 2024, 74 (04) : 693 - 708
  • [24] Prevalence of potential drug-drug interactions (PDDIS) in patients treated with oral cancer drugs in Fatebenefratelli Hospital in Milan
    Galfrascoli, E.
    Gambitta, L.
    Moretti, A.
    Dazzani, C.
    Muserra, G.
    Farina, G.
    Saporito, T.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (03) : 733 - 733
  • [25] Prevalence and predictors of potential drug-drug interactions in patients of internal medicine wards of a tertiary care hospital in India
    Bethi, Yugandhar
    Shewade, Deepak Gopal
    Dutta, Tarun Kumar
    Gitanjali, Batmanabane
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2018, 25 (06) : 317 - 321
  • [26] Patients with dementia: prevalence and type of drug-drug interactions
    Munoz-Contreras, Maria Cristina
    Cerda, Begona
    Lopez-Roman, Francisco Javier
    Segarra, Ignacio
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [27] Prevalence of potential drug-drug interactions in Swedish pediatric outpatients
    Holm, Johan
    Eiermann, Birgit
    Kimland, Elin
    Mannheimer, Buster
    PLOS ONE, 2019, 14 (08):
  • [28] The prevalence of potential drug-drug interactions in adults with intellectual disability
    McMahon, M.
    Hatton, C.
    Bowring, D. L.
    Hardy, C.
    Preston, N. J.
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2021, 65 (10) : 930 - 940
  • [29] Prevalence of potential drug-drug interactions and its associated factors in a Brazilian teaching hospital.
    Cruciol-Souza, Joice Mara
    Thomson, Joao Carlos
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2006, 9 (03): : 427 - 433
  • [30] Prevalence, types and predictors of potential drug-drug interactions in pulmonology ward of a tertiary care hospital
    Ismail, Mohammad
    Iqbal, Zafar
    Khattak, Muhammad Bilal
    Javaid, Arshad
    Khan, Tahir Mehmood
    AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY, 2011, 5 (10): : 1303 - 1309
12345